Why Attend?

  • To share a better understanding of the mechanics of the EPA to formulate improved business opportunities

  • Learn about trade openings and how to maximise results using the EPA platform.

  • Gain valuable expert insight and meet with key EPA policy-stakeholders, country and government trade representatives.

  • Network with business leaders from Europe and Japan looking to capitalise on the EPA potential

  • Attend one-on-one scheduled meetings with advisors representing industry opportunities.

  • Build relations with global bankers, financial and technical advisors, and business strategists focused on the EPA benefits.

  • Join a global network of business leaders, policy stakeholders, regulatory and technical experts to help build a robust EU-Japan EPA strategy.

Event Objective

The EU-Japan EPA Forum and Round Table Series objective is to support the global business community with better understanding the EPA value and how to leverage the opportunities arising valued at an estimated EUR 900 Bn in total.

Through the engagement of key policy and business stakeholders, industry thought-leaders, think-tanks, country-, industry associations and media internationally, we aim to deliver a series of world-class EU-Japan trade and investment focused events.

Who will attend?

  • EU-Japan Policy Stakeholders

  • C-Level Executives

  • EVPs, VPs and Country Managers

  • Legal, Regulatory and Compliance

  • Industry Experts, Trade and Government Representatives

  • Financial, Legal and Business Advisors

  • EU and Japan focused Business Stakeholders

EUJapan_CLU7996.jpg

Key Event Details

Event: 2nd EU-Japan EPA Forum

Location: Milan, Italy

Dates: 16-17 May, 2019

Venue: Hotel Principe Di Savoia

Attendance: 350 Senior Delegates

Subject: Commercialisation of the EU-Japan EPA, Trade Deal

Objective: Assist companies with unlocking the deal, valued at an est. EUR 900 Bn.

Industries in focus: Automotive, Aviation, Electronics, Machinery, Foods & Agriculture, Textiles And Leather Goods, Pharmaceutical, Medical Devices, Chemicals, Technology Transfer, Financial Services And Insurance.